Investor082
19 minutes ago
I agree. The UK approval alone will not do much in terms of share price except for a momentary spike of 100% or so, which shorts will take advantage of. With no hiring, reimbursement support, or non dilutive funds from big pharma, the shorts know that NWBO is several years away from generating any m